TY - JOUR
T1 - Reductions in sexually transmitted infections associated with popular opinion leaders in China in a randomised controlled trial
AU - Rotheram-Borus, Mary Jane
AU - Wu, Zunyou
AU - Liang, Li Jung
AU - Li, Li
AU - Detels, Roger
AU - Guan, Jihui
AU - Yin, Yueping
AU - Swendeman, Dallas
AU - Caceres, Carlos
AU - Celentano, David
AU - Coates, Thomas
AU - Hartwell, Tyler
AU - Kasprzyk, Danuta
AU - Kelly, Jeffrey
AU - Kozlov, Andrei
AU - Pequegnat, Willo
AU - Solomon, Suniti
AU - Woelk, Godfrey
PY - 2011/6
Y1 - 2011/6
N2 - Objectives: A community level randomised controlled trial of a Community Popular Opinion Leader (C-POL) intervention to reduce bacterial and viral sexually transmitted infections (STIs) and unprotected extramarital sex was carried out over 2 years in five countries. The main study results did not find significant intervention effects. This paper presents a sub-analysis examining the differential intervention impacts among high-risk and low-risk participants in the China site. Methods: From 2002-2006, 3912 migrant market vendors aged 18 and 49 years were recruited at an urban site in China. Markets were randomly assigned to the C-POL intervention (N=20 markets; n=1979) or standard-care control condition (N=20; n=1933). Both study condition venues received HIV/STI education, free condoms, STI testing and treatment, and training for pharmacists in antibiotic treatments. In intervention markets, C-POLs were identified and trained to diffuse messages regarding safer sex, STI treatment and partner discussions of sex. The primary biological outcome was incidence of new STIs (chlamydia, gonorrhoea, syphilis, trichomonas, herpes or HIV). The primary sexual behaviour risk outcome was any unprotected extramarital sex in the prior 3 months. Results: In unadjusted analyses, women had significantly lower rates of STI infection at 24 months in the C-POL intervention (5.7%) compared to controls (8.3%; p=0.043). In mixed-effects regression models, intervention participants with STIs at previous assessments were about half as likely to have STIs at 24 months (OR 0.47, 95% CI 0.25 to 0.90) compared to controls. Conclusions: The C-POL intervention lowers HIV risk among those at highest risk (ie, with a STI or engaging in high-risk sexual activities) rather than the general population. Trial registration: http://Clinicaltrials.gov/ identifier NCT 00710060.
AB - Objectives: A community level randomised controlled trial of a Community Popular Opinion Leader (C-POL) intervention to reduce bacterial and viral sexually transmitted infections (STIs) and unprotected extramarital sex was carried out over 2 years in five countries. The main study results did not find significant intervention effects. This paper presents a sub-analysis examining the differential intervention impacts among high-risk and low-risk participants in the China site. Methods: From 2002-2006, 3912 migrant market vendors aged 18 and 49 years were recruited at an urban site in China. Markets were randomly assigned to the C-POL intervention (N=20 markets; n=1979) or standard-care control condition (N=20; n=1933). Both study condition venues received HIV/STI education, free condoms, STI testing and treatment, and training for pharmacists in antibiotic treatments. In intervention markets, C-POLs were identified and trained to diffuse messages regarding safer sex, STI treatment and partner discussions of sex. The primary biological outcome was incidence of new STIs (chlamydia, gonorrhoea, syphilis, trichomonas, herpes or HIV). The primary sexual behaviour risk outcome was any unprotected extramarital sex in the prior 3 months. Results: In unadjusted analyses, women had significantly lower rates of STI infection at 24 months in the C-POL intervention (5.7%) compared to controls (8.3%; p=0.043). In mixed-effects regression models, intervention participants with STIs at previous assessments were about half as likely to have STIs at 24 months (OR 0.47, 95% CI 0.25 to 0.90) compared to controls. Conclusions: The C-POL intervention lowers HIV risk among those at highest risk (ie, with a STI or engaging in high-risk sexual activities) rather than the general population. Trial registration: http://Clinicaltrials.gov/ identifier NCT 00710060.
UR - http://www.scopus.com/inward/record.url?scp=79956274758&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79956274758&partnerID=8YFLogxK
U2 - 10.1136/sti.2010.046243
DO - 10.1136/sti.2010.046243
M3 - Article
C2 - 21278400
AN - SCOPUS:79956274758
SN - 1368-4973
VL - 87
SP - 337
EP - 343
JO - Sexually transmitted infections
JF - Sexually transmitted infections
IS - 4
ER -